Risk of urogenital infections in non-diabetic patients treated with sodium glucose transporter 2 (SGLT2) inhibitors. Systematic review and meta-analysis

Risk of urogenital infections in non-diabetic patients treated with sodium glucose transporter 2 (SGLT2) inhibitors. Systematic review and meta-analysis

Although SGLT2 inhibitors have been initially employed in the treatment of type 2 diabetes, their clinical use was later extended to the treatment of other conditions such as heart failure, chronic kidney disease and obesity. In patients with type 2 diabetes, the administration of SGLT2 inhibitors...

Full description

Bibliographic Details
Main Authors: Rawa Bapir, Kamran Hassan Bhatti, Ahmed Eliwa, Herney Andrés García-Perdomo, Nazim Gherabi, Derek Hennessey, Vittorio Magri, Panagiotis Mourmouris, Adama Ouattara, Gianpaolo Perletti, Joseph Philipraj, Konstantinos Stamatiou, Musliu Adetola Tolani, Lazaros Tzelves, Stefan D. Anker, Alberto Trinchieri, Noor Buchholz
Format: Article
Language:English
Published: PAGEPress Publications 2023-06-01
Series:Archivio Italiano di Urologia e Andrologia
Subjects:
Sodium glucose transporter 2 (SGLT2) inhibitors
Urinary tract infections
Genital infections
Candidiasis
Heart failure
Chronic kidney disease
Online Access:https://www.pagepressjournals.org/index.php/aiua/article/view/11509

Internet

https://www.pagepressjournals.org/index.php/aiua/article/view/11509

Similar Items